ClinicalTrials.Veeva

Menu

Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis

National Taiwan University logo

National Taiwan University

Status and phase

Unknown
Phase 1

Conditions

Osteoporosis

Treatments

Drug: Gu-Sui-Bu (Davallia Divaricata)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

We, the investigators at National Taiwan University Hospital, have determined the therapeutic and toxic effects of the traditional herb on the ovariectomized Wistar rat.

The final years will determine its effects on the therapy of women who are over 45 years old and postmenopausal with osteoporosis.

Full description

Research of this traditional chinese clinical medicine, Gusuibu, curative effect is planned for three years time. The entire study aims to evaluate the effect of the traditional chinese medicine on postmenopausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal women with established osteoporosis.

Sex

Female

Ages

45 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Postmenopausal osteoporosis

Exclusion criteria

  • Insulin dependent diabetes

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Central trial contact

Liu Hwa-Chang, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems